Skip to main content

Table 2 Clinicopathologic feature of 71 mucinous breast cancers in 1760 breast carcinomas

From: Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma

Parameters MBC (n=71) Non-MBC(n=1689) p value
Age at operation 38 (53.5%) 965 (57.1%) 0.547
  ≤64 33 (46.5%) 724 (42.9%)  
  >64    
Pathological stage 23 (32.4%) 799 (47.3%) 0.014
  I 48 (67.6%) 890 (52.7%)  
  II and III    
pTumor size 25 (35.2%) 937 (55.5%) 0.001
  ≤2 cm 46 (64.8%) 752 (45.5%)  
  >2 cm    
pLymph node status 63 (88.7%) 1270 (75.2%) 0.009
  Negative 8 (11.3%) 419 (24.8%)  
  Positive    
Lymphovascular invasion 56 (78.9%) 1276 (75.5%) 0.522
  Negative 15 (21.1%) 413 (24.5%)  
  Positive    
HR (ER and/or PR) 3 (4.2%) 477 (28.2%) < 0.001
  Negative 68 (95.8%) 1212 (71.8%)  
  Positive    
HER 2 status 70 (98.6%) 1310 (77.6%) < 0.001
  Negative 1 (1.4%) 379 (22.4%)  
  Positive    
  1. MBC mucinous breast carcinoma.
  2. HR Hormone receptor.